APAC In-Vitro Toxicology Testing Market Size & Growth (2019 – 2024)
The In-Vitro Toxicology Testing Market in the Asia Pacific is expected to reach USD 7073 Million by 2024 from USD 3336 Million in 2019, growing at a CAGR of 16.22% for the next five years 2019-2024.
In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.
Increasing demand for advanced toxicity testing methods, rising investments in research, growing healthcare infrastructure, and increasing government initiatives to enhance research in academics & private organizations to promote technologies are driving the growth of in-vitro toxicology testing market in Asia-Pacific region. However, high cost of the toxicology testing technologies & procedures and low adoption of advanced toxicology testing procedures are restraining the growth of Asia-Pacific in-vitro toxicology testing market.
This research report segmented and sub-segmented into the following categories:
By Product: Assays, Reagents & Labware & Services
On the basis of product type, the Assays segment is estimated to command the largest share of the APAC in-vitro toxicology testing market by product in 2018. Systemic toxicity is estimated to command the largest share of APAC in-vitro toxicology testing market by toxicity endpoints & tests in 2016. Technology is further segmented as OMICS technologies & cell culture technology.
By Type: ADME, Dose & Toxic Substance
By Toxicity Endpoints & Tests: Carcinogenicity, Dermal Toxicity & Genotoxicity
By Technology: OMICS Technologies, Cell Culture Technology
By Method: Cellular Assays, In-Silico Method
On the basis of Method, the In-silico method is estimated to command the largest share of APAC in-vitro toxicology testing market by method in 2018. The cosmetics & household products industry is estimated to account for the largest market share of the APAC in-vitro toxicology testing market by industry in 2018.
By Industry: Cosmetics & Household Products, Pharmaceutical
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC
On the basis of geographical areas, Japan is estimated to account for the largest share of the Asia-Pacific in-vitro toxicology testing market in 2018, whereas India is estimated to grow at the highest CAGR during the forecast period.
Companies leading the APAC In-Vitro Toxicology Testing Market profiled in this report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Assays
5.1.3 Reagents & Labware
5.1.4 Services Growth Hormone Therapy
5.2 Type
5.2.1 Introduction
5.2.2 ADME (Absorption, Distribution, Metabolism, and Excretion)
5.2.3 Dose
5.2.4 Toxic Substance
5.3 Toxicity Endpoints & Tests
5.3.1 Introduction
5.3.2 Systemic Toxicity
5.3.3 Dermal Toxicity
5.3.4 Carcinogenicity
5.3.5 Ocular Toxicity
5.3.6 Skin Sensitization & Irritation
5.3.7 Genotoxicity
5.3.8 Neurotoxicity
5.3.9 Organ Toxicity
5.3.10 Other Toxicity Endpoints & Tests
5.4 Technology
5.4.1 Introduction
5.4.2 OMICS Technologies
5.4.3 Cell Culture Technology
5.4.4 High-Throughput Technologies
5.4.5 Molecular Imaging Technologies
5.5 Method
5.5.1 Introduction
5.5.2 In-Silico Methods
5.5.3 Biochemical Assays
5.5.4 Cellular Assays
5.5.5 Ex-Vivo Models
5.6 Industry
5.6.1 Introduction
5.6.2 Cosmetics and Household Products
5.6.3 Diagnostics
5.6.4 Pharmaceuticals
5.6.5 Food Industry
5.6.6 Chemicals
6. Geographical Analysis
6.3 Asia-Pacific
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Covance, Inc. (A subsidiary of LabCorp) (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Agilent Technologies, Inc. (U.S.)
8.3 Bio-Rad Laboratories, Inc. (U.S.)
8.4 Eurofins Scientific SE (Luxembourg)
8.5 General Electric Company (U.S.)
8.6 BioReliance, Inc. (U.S.)
8.7 Charles River Laboratories International, Inc. (U.S.)
8.8 Thermo Fisher Scientific, Inc. (U.S.)
8.9 Catalent (U.S.)
8.10 Cyprotex (U.K.)
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
